Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) Net Margin (2016 - 2025)

Wave Life Sciences' Net Margin history spans 11 years, with the latest figure at 580.17% for Q2 2025.

  • For Q2 2025, Net Margin fell 41298.0% year-over-year to 580.17%; the TTM value through Dec 2025 reached 1143.44%, down 110157.0%, while the annual FY2025 figure was 478.33%, 38876.0% down from the prior year.
  • Net Margin reached 580.17% in Q2 2025 per WVE's latest filing, down from 510.93% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 14.78% in Q3 2023 to a low of 13685.61% in Q3 2022.
  • Average Net Margin over 5 years is 1885.71%, with a median of 189.58% recorded in 2023.
  • Peak YoY movement for Net Margin: crashed -1366851bps in 2022, then surged 1370040bps in 2023.
  • A 5-year view of Net Margin shows it stood at 44.65% in 2021, then decreased by -21bps to 53.83% in 2022, then skyrocketed by 76bps to 12.68% in 2023, then skyrocketed by 216bps to 14.66% in 2024, then crashed by -4057bps to 580.17% in 2025.
  • Per Business Quant, the three most recent readings for WVE's Net Margin are 580.17% (Q2 2025), 510.93% (Q1 2025), and 14.66% (Q4 2024).